PCIA
GILD icon

Prime Capital Investment Advisors’s Gilead Sciences GILD Stock Holding History

Prime Capital Investment Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.24M Sell
16,052
-3,202
-17% -$448K 0.03% 343
2025
Q4 		$2.36M Sell
19,254
-534
-3% -$64.9K 0.03% 325
2025
Q3 		$2.2M Sell
19,788
-421
-2% -$47.9K 0.03% 324
2025
Q2 		$2.24M Sell
20,209
-5,169
-20% -$550K 0.03% 311
2025
Q1 		$2.84M Buy
25,378
+3,201
+14% +$330K 0.03% 305
2024
Q4 		$2.05M Sell
22,177
-2,654
-11% -$239K 0.03% 296
2024
Q3 		$2.08M Sell
24,831
-14,908
-38% -$1.14M 0.03% 304
2024
Q2 		$2.73M Sell
39,739
-9,233
-19% -$616K 0.04% 271
2024
Q1 		$3.59M Sell
48,972
-22,969
-32% -$1.77M 0.05% 248
2023
Q4 		$5.83M Buy
71,941
+39,558
+122% +$3.08M 0.09% 181
2023
Q3 		$2.43M Sell
32,383
-3,360
-9% -$258K 0.05% 230
2023
Q2 		$2.75M Buy
35,743
+15,961
+81% +$1.27M 0.05% 228
2023
Q1 		$1.64M Sell
19,782
-3,528
-15% -$292K 0.07% 187
2022
Q4 		$2M Buy
23,310
+14,086
+153% +$1.12M 0.08% 174
2022
Q3 		$569K Buy
9,224
+5,969
+183% +$376K 0.03% 223
2022
Q2 		$201K Buy
+3,255
New +$202K 0.01% 360
2021
Q2 		– Sell
-929
Closed -$60K – 441
2021
Q1 		$60K Sell
929
-438
-32% -$28.2K ﹤0.01% 323
2020
Q4 		$80K Sell
1,367
-50,738
-97% -$3.06M 0.01% 290
2020
Q3 		$3.29M Sell
52,105
-11,469
-18% -$795K 0.28% 70
2020
Q2 		$4.89M Buy
63,574
+62,397
+5,301% +$4.78M 0.46% 46
2020
Q1 		$88K Buy
1,177
+967
+460% +$66.8K 0.01% 253
2019
Q4 		$14K Sell
210
-2,188
-91% -$142K ﹤0.01% 457
2019
Q3 		$152K Sell
2,398
-32,819
-93% -$2.15M 0.02% 214
2019
Q2 		$2.38M Sell
35,217
-333
-0.9% -$21.9K 0.43% 69
2019
Q1 		$2.31M Sell
35,550
-7,027
-17% -$467K 0.67% 45
2018
Q4 		$2.66M Buy
42,577
+1,027
+2% +$71.8K 0.97% 28
2018
Q3 		$3.21M Buy
41,550
+11,915
+40% +$900K 1.02% 33
2018
Q2 		$2.1M Buy
29,635
+29,391
+12,045% +$2.08M 0.88% 38
2018
Q1 		$18K Sell
244
-35,056
-99% -$2.79M 0.01% 194
2017
Q4 		$2.53M Buy
+35,300
New +$2.68M 1.95% 17

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Prime Capital Investment Advisors's GILD Position: Q1 2026 in Review

Prime Capital Investment Advisors reduced its Gilead Sciences (GILD) stake by 17% in Q1 2026, selling an estimated $448K and leaving 16,052 shares worth $2.24M. The position accounts for 0.03% of the portfolio, ranked #343.

Prime Capital Investment Advisors first reported a position in GILD in Q4 2017 and has held it in 30 quarters since. The position peaked at $5.83M in Q4 2023. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Prime Capital Investment Advisors held 16,052 shares of Gilead Sciences worth $2.24M as of Q1 2026.
  • Prime Capital Investment Advisors sold 3,202 Gilead Sciences shares in Q1 2026, an estimated $448K.
  • Gilead Sciences made up 0.03% of Prime Capital Investment Advisors's portfolio in Q1 2026, its #343 holding.
  • Prime Capital Investment Advisors first reported a position in Gilead Sciences in Q4 2017 and has held it in 30 quarters since.
  • Prime Capital Investment Advisors's Gilead Sciences position peaked at $5.83M in Q4 2023.
  • 2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Prime Capital Investment Advisors's 13F filing for Q1 2026, filed 8 May 2026.